Basit öğe kaydını göster

Intravenous iloprost for treatment of critical limb ischemia in patients unsuitable for revascularization

dc.contributor.authorErdem, Hasan
dc.contributor.authorBozkurt, Kursat
dc.contributor.authorGul, Yasar Gokhan
dc.contributor.authorAdademir, Taylan
dc.contributor.authorKoksal, Cengiz
dc.contributor.authorCevirme, Deniz
dc.contributor.authorAksoy, Eray
dc.date.accessioned2021-03-05T07:52:25Z
dc.date.available2021-03-05T07:52:25Z
dc.date.issued2015
dc.identifier.citationCevirme D., Aksoy E., Gul Y. G. , Erdem H., Adademir T., Koksal C., Bozkurt K., "Intravenous iloprost for treatment of critical limb ischemia in patients unsuitable for revascularization", VASCULAR, cilt.23, ss.483-489, 2015
dc.identifier.issn1708-5381
dc.identifier.otherav_95ff2411-dcad-44bb-ad92-051c70e3b69f
dc.identifier.othervv_1032021
dc.identifier.urihttp://hdl.handle.net/20.500.12627/100986
dc.identifier.urihttps://doi.org/10.1177/1708538114552839
dc.description.abstractIntroduction: Whether medical therapy alone may reduce the amputation rates in patients with chronic limb ischemia and who are unsuitable for revascularization is a controversial topic. In this study, we aimed to investigate the effects of 1 week infusion of iloprost in the treatment of patients with chronic limb ischemia.
dc.language.isoeng
dc.subjectKlinik Tıp (MED)
dc.subjectSağlık Bilimleri
dc.subjectPERİFERAL VASKÜLER HASTALIĞI
dc.subjectKlinik Tıp
dc.subjectTıp
dc.titleIntravenous iloprost for treatment of critical limb ischemia in patients unsuitable for revascularization
dc.typeMakale
dc.relation.journalVASCULAR
dc.contributor.departmentIstanbul Kartal Kosuyolu Yuksek Ihtisas Training & Research Hospital , ,
dc.identifier.volume23
dc.identifier.issue5
dc.identifier.startpage483
dc.identifier.endpage489
dc.contributor.firstauthorID225202


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster